Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 16 studies | 80% ± 13% | |
oligodendrocyte precursor cell | 13 studies | 45% ± 19% | |
GABAergic neuron | 10 studies | 61% ± 24% | |
endothelial cell | 9 studies | 43% ± 17% | |
glutamatergic neuron | 8 studies | 43% ± 19% | |
astrocyte | 7 studies | 35% ± 19% | |
interneuron | 6 studies | 56% ± 26% | |
retinal ganglion cell | 6 studies | 45% ± 22% | |
amacrine cell | 6 studies | 43% ± 22% | |
neuron | 5 studies | 36% ± 12% | |
microglial cell | 4 studies | 44% ± 14% | |
GABAergic amacrine cell | 4 studies | 51% ± 21% | |
retinal bipolar neuron | 4 studies | 33% ± 14% | |
GABAergic interneuron | 3 studies | 60% ± 25% | |
ON-bipolar cell | 3 studies | 28% ± 9% | |
rod bipolar cell | 3 studies | 53% ± 11% | |
basal cell | 3 studies | 17% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 17 studies | 43% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 5865.79 | 2639 / 2642 | 89% | 31.80 | 626 / 705 |
prostate | 94% | 2746.13 | 231 / 245 | 94% | 25.81 | 470 / 502 |
adrenal gland | 15% | 208.48 | 39 / 258 | 65% | 94.21 | 150 / 230 |
ovary | 34% | 372.98 | 61 / 180 | 14% | 1.83 | 62 / 430 |
bladder | 14% | 99.86 | 3 / 21 | 15% | 4.53 | 77 / 504 |
lung | 0% | 0.95 | 1 / 578 | 21% | 3.27 | 238 / 1155 |
uterus | 6% | 54.07 | 10 / 170 | 14% | 2.68 | 62 / 459 |
esophagus | 6% | 50.07 | 87 / 1445 | 13% | 1.18 | 24 / 183 |
pancreas | 0% | 0 | 0 / 328 | 13% | 2.58 | 23 / 178 |
thymus | 0% | 17.40 | 2 / 653 | 11% | 1.76 | 68 / 605 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.44 | 2 / 29 |
liver | 0% | 0 | 0 / 226 | 4% | 1.61 | 15 / 406 |
skin | 0% | 0.29 | 1 / 1809 | 2% | 1.97 | 11 / 472 |
intestine | 1% | 5.86 | 9 / 966 | 1% | 0.17 | 7 / 527 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.08 | 1 / 45 |
breast | 1% | 5.22 | 4 / 459 | 1% | 0.20 | 8 / 1118 |
eye | 0% | 0 | 0 / 0 | 1% | 0.10 | 1 / 80 |
spleen | 1% | 4.10 | 2 / 241 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 1% | 0.36 | 7 / 901 |
stomach | 0% | 0 | 0 / 359 | 1% | 0.22 | 2 / 286 |
blood vessel | 0% | 0.30 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0010951 | Biological process | negative regulation of endopeptidase activity |
GO_2000146 | Biological process | negative regulation of cell motility |
GO_0005576 | Cellular component | extracellular region |
GO_0005509 | Molecular function | calcium ion binding |
GO_0008191 | Molecular function | metalloendopeptidase inhibitor activity |
GO_0005539 | Molecular function | glycosaminoglycan binding |
Gene name | SPOCK3 |
Protein name | SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3 (cDNA FLJ59873, highly similar to Testican-3) Testican-3 (SPARC/osteonectin, CWCV, and Kazal-like domains proteoglycan 3) SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3 Alternative protein SPOCK3 SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3 (Sparc/osteonectin, cwcv and kazal-like domains proteoglycan (Testican) 3, isoform CRA_b) |
Synonyms | TICN3 tmp_locus_3 UNQ409/PRO771 hCG_1811376 |
Description | FUNCTION: May participate in diverse steps of neurogenesis. Inhibits the processing of pro-matrix metalloproteinase 2 (MMP-2) by MT1-MMP and MT3-MMP. May interfere with tumor invasion. |
Accessions | ENST00000357154.7 [Q9BQ16-3] ENST00000512681.5 [Q9BQ16-5] ENST00000512648.5 [Q9BQ16-9] ENST00000502741.5 ENST00000535728.5 L8E8K0 ENST00000502821.5 ENST00000506697.5 ENST00000509854.5 A0A0A0MTJ2 ENST00000510403.5 E7ESN1 ENST00000511226.5 E7EVH4 ENST00000507370.5 Q4W5S3 B4DG04 ENST00000515143.5 ENST00000504953.5 [Q9BQ16-1] ENST00000506886.5 [Q9BQ16-3] ENST00000511269.5 [Q9BQ16-1] ENST00000511905.5 ENST00000502330.5 [Q9BQ16-3] ENST00000505187.5 E7ENT7 E7ENY3 E7ENM6 Q9BQ16 ENST00000357545.9 [Q9BQ16-1] ENST00000512042.1 ENST00000511531.5 [Q9BQ16-3] ENST00000515316.5 E7EQ24 ENST00000507086.5 ENST00000421836.6 [Q9BQ16-4] ENST00000541354.5 [Q9BQ16-7] E7EMP8 H0YA19 ENST00000510741.5 [Q9BQ16-8] |